| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000029127 |
| Receipt No. | R000033306 |
| Scientific Title | The trial for effect of RFX on hepatic encepalopathy |
| Date of disclosure of the study information | 2017/09/13 |
| Last modified on | 2019/11/29 (Ver. 3) |
| Basic information | ||
| Public title | The trial for effect of RFX on hepatic encepalopathy | |
| Acronym | The study of the effect of RFX | |
| Scientific Title | The trial for effect of RFX on hepatic encepalopathy | |
| Scientific Title:Acronym | The study of the effect of RFX | |
| Region |
|
|
| Condition | ||
| Condition | hepatic encephalopathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | We investigate the effect of RFX on HE |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1.Improvment of HE
2.Improvment of the intestinal becterial flora |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)>20 years old
2)The patients obtained the consent 3)>4 weeks of suvival periods 4)AST and ALT > 6 times from the facilities standards |
|||
| Key exclusion criteria | 1)The impossible of oral intake
2)The pharmacokinetics in changed for patient's condition 3)The necessary medicine change the pharmacokinetics of rifaximin 4)The pregnancy and lactaing 5)The allergy of rifaximin 6)The outcome evaluation is difficult for patient's condition 7)The execution plan of achievement is difficult |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nara medical unversity | ||||||
| Division name | 3rd department of interanal medicine | ||||||
| Zip code | 6348521 | ||||||
| Address | 840,Shijo-cho, Kashihara, Nara | ||||||
| TEL | 0744-22-3051 | ||||||
| htky@naramed-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nara medical unversity | ||||||
| Division name | 3rd department of interanal medicine | ||||||
| Zip code | 6348521 | ||||||
| Address | 840,Shijo-cho, Kashihara, Nara | ||||||
| TEL | 0744-22-3051 | ||||||
| Homepage URL | |||||||
| htky@naramed-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nara medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nara medical university |
| Address | 840,Shijo-cho, Kashihara, Nara |
| Tel | 0744223051 |
| htky@naramed-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | nothing |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033306 |